The increase, in the last two decades, in the application of silicones (pol
ysiloxanes) and inorganic silicon compounds in medicine and the food indust
ry, has exposed the human body to extensive contacts with these substances.
Most silicone breast implants contain a gel consisting of a crosslinked si
licone elastomer swollen by silicone oil (PDMS). Diffusion of PDMS through
the silicone elastomer envelope and rupture of the envelope with release of
the gel contents both occur clinically. The amount and distribution of sil
icone compounds in Various tissues are key issues in the assessment of heal
th problems connected with silicone implants.
We have measured by GFAAS the Si content of tissues from normal and implant
patients and the organic solvent extractable Si levels (assumed to be sili
cone), using careful control of sample collection and preparation. Whole bl
ood levels were: implant patients mean 38.8 (SD 25.6) (mu g/kg), controls m
ean 24.2 (SD 26.7) (mu g/kg) in one study and subsequently 103.8 (SD 112.1)
and 74.3 (SD 86.5) (mu g/kg) in another study. Capsular tissue levels were
: gel implants 25047 (SD 39313) (mg/kg of dry tissue), saline implants 20.0
(SD 27.3) (mg/kg of dry tissue) and controls 0.24 (SD 0.39) (mg/kg of dry
tissue). Breast milk levels were: implant patients mean 58.7 (SD 33.8) (mu
g/kg), controls mean 51.1 (SD 31.0) (mu g/kg); infant formula mean was 4.40
(mg/kg). Various precautions were undertaken to avoid Si contamination in
this work, the most important being a) the use of a Class 100 laboratory fo
r sample preparation and b) application of strict and elaborate washing pro
cedure for specimen collection tools and laboratory plasticware.
This data demonstrated that to properly interpret the importance of these n
umbers for human health, a larger study of "normal" levels of Si in human t
issues should be undertaken and factors such as diet, water, race and geogr
aphical location should be considered.